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Abstract
Background: The UK Medical Research Council has proposed that complex interventions should
be tested in exploratory trials prior to a full-scale trial so as to better define the intervention and
test the feasibility of components such as recruitment. It is not clear to what extent this is being
done. This study aimed to determine to what extent complex interventions are tested prior to a
full-scale trial and whether more or different testing would have led to a different intervention
being used in the trial.
Methods: Email survey of the authors of complex intervention trials published in seven major
journals in 2004.
Results: 72% (50/69) of eligible authors replied. Eight authors did not consider their interventions
to be complex. The majority of respondents' complex interventions were tested (34/42): some
extensively. Conversely, only 17 of the 34 published reports describing these trials mention testing.
Two-thirds (22/34) of those testing their interventions did not believe that more or different
testing would have produced a more effective intervention. 31% (13/42) of all authors did believe
further testing would have led to improvements. Five respondents mentioned a lack of funding as
a reason for not doing more testing.
Conclusion: Complex interventions are generally tested prior to their evaluation in a full-scale
trial, although the amount of testing varies. Testing is often not described in trial reports, which
makes it hard to judge whether a trial result could be improved with a better intervention, or
whether further work with a different intervention is required.
Background
In 2000 the UK Medical Research Council published a
structure for evaluating complex interventions, which
proposed that interventions should be modelled and then
tested prior to a full-scale trial [1]. The pre-trial work
could be expected to provide a more realistic estimate of
the likely effect of the intervention and inform decisions
regarding intervention design and delivery. In principle,
such work may help to avoid wasting resources evaluating
ineffective interventions because rigorous development
and testing will reject poor interventions and unfeasible
trials before they reach full-scale evaluation [2,3].
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The aim of the current study was twofold. Firstly, we
wanted to survey the estimates of treatment effect and
recruitment given in trial reports and compare them with
those actually achieved, together with any mention of
piloting or testing. Secondly, we wanted to ask the authors
of these trial reports whether testing did influence the
design of their trials and whether more or different testing
would have led to a different intervention being devel-
oped. This paper deals with the second of these; the first is
covered in a sister paper [4].
Methods
We searched the 2004 issues of the British Journal of Gen-
eral Practice (BJGP), the BMJ, Family Practice, the Journal
of the American Medical Association (JAMA), the Journal
of the American Medical Informatics Association
(JAMIA), the Journal of Health Services Research and Pol-
icy (JHSRP) and the Lancet for articles indexed in Pubmed
as 'randomized controlled trials'. We did this by using
Pubmed's 'Limits' facility to restrict the type of article
retrieved to randomized controlled trials. These journals
were selected because they are high impact journals with
a history (in our experience) of publishing reports of ran-
domised controlled trials. We limited ourselves to these
seven journals because we thought it would be unwise to
commit resources to a systematic review without having a
much better idea of the type and extent of pre-trial testing
done in complex intervention studies. The current study
can be seen as a pilot that can inform the development of
a search strategy, inclusion criteria and selection of out-
come measures for a larger systematic study.
We had two further inclusion criteria:
• the intervention must be complex
￿ trials must address patient care or provision of care by
health professionals
To select complex intervention trials we used the MRC
definition of a complex trial: 'Complex interventions in
health care, whether therapeutic or preventative, comprise a
number of separate elements which seem essential to the proper
functioning of the intervention although the active ingredient
of the intervention that is effective is difficult to specify. ' [1].
This definition is open to interpretation. Interventions
that we considered complex under this definition
included the use of volunteer counsellors to increase
breast-feeding, a behavioural intervention to reduce
acquisition of HIV among homosexual men and the use
of a structured shared care model involving education, a
nurse specialist, locally agreed treatment protocols and
improved primary care-secondary care communication to
improve the management of diabetes in primary care.
Interventions that we did not consider complex included
a comparison of five antimicrobial regimens for mild to
moderate facial acne, a study of a computerised guideline
system that measured physician knowledge but not the
care provided, using an invitation to ultrasound screening
to reduce mortality from abdominal aortic aneurysm and
adenotonsillectomy compared with watchful waiting in
the treatment of mild symptoms of throat infections or
adenotonsillar hypertrophy. These and similar interven-
tions were excluded because they involved a single com-
ponent where the active ingredient was clear or because
they did not involve patient care.
Abstracts were scanned for relevance by both authors and
relevant abstracts were discussed and any disagreements
resolved. The full text of included studies was obtained
and ST did data extraction. Of the 318 articles identified
by our search, 70 met our inclusion criteria (28 from the
BMJ, 17 from JAMA, ten from the Lancet, eight from Fam-
ily Practice, seven from BJGP and none from both JAMIA
and JHSRP. A five-question email questionnaire was sent
to the corresponding author of each of the 70 included
studies. The questionnaire was piloted on colleagues prior
to its use in the survey although no changes to the ques-
tionnaire's wording or general design were suggested. A
full copy of the questionnaire is given in the Appendix.
The email sent to authors also assured them that they
would remain anonymous in any future publications. A
single reminder was sent one week after the initial email.
Results
One email was incorrect and an alternative address could
not be found; 72% (50/69) of the remaining authors
replied but eight of these did not consider their interven-
tions to be complex. The results presented below come
from the responses of the remaining 42 authors.
The majority of interventions were tested (34/42 or 81%;
95% confidence interval = 67% to 90%), some extensively
(Table 1). Conversely, only 17 (or 50%; 95% Cl = 34% to
66%) of the 34 trials that involved testing actually men-
tion this testing in the published report. Those not men-
tioning their testing included some studies that ran
substantial testing programs prior to the intervention's
evaluation in a full-scale trial. Of the 34 respondents who
said their interventions were tested, 22 (or 65%; 95% Cl =
48% to 79%) did not believe that different or further test-
ing would have produced a more effective intervention.
Four of those who did no testing thought that more test-
ing would have improved their intervention. The 13
respondents who did believe further testing would have
led to improvements gave the following reasons: better
intervention (five respondents); better delivery (two); bet-
ter intervention and delivery (two); more understanding
of how intervention components work (one); andBMC Medical Research Methodology 2006, 6:28 http://www.biomedcentral.com/1471-2288/6/28
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unspecified (three). Five respondents mentioned a lack of
funding as a reason for not doing more testing. Table 2
presents some illustrative comments from these 13
respondents; almost all those saying that different or fur-
ther testing would not have produced a more effective
intervention simply replied 'No'.
The testing that was done influenced the interventions in
a variety of ways. Some of the testing would be relevant for
any intervention trial (eg. testing of data collection instru-
ments or training manuals) and not just those involving a
complex intervention. Reported testing could be catego-
rised as: iterative refinements of the intervention and/or
its delivery (20 respondents; altered the trial design
(three); altered both intervention and trial design (three);
confirmed the feasibility of the trial (three); changed
nothing (two); and unclear what influence testing had
(three). Where trial design was changed, pre-trial testing
led to an arm of the trial being dropped in three cases.
Examples of how testing influenced the full-scale trial are
given in Table 3. The type of information we received
from respondents is very close to the short statement for-
mat given in Table 3.
Discussion
Most of the complex interventions evaluated by the 42
respondents were tested to some extent but this work does
not always find its way into published trial reports, which
leads to an incomplete description of the rationale for
intervention choice. There were no clear differences
between the trials of responders and non-responders
although only five of the 19 non-responders (or 26%)
mentioned testing in the trial report, which is about two-
thirds the rate of responders (40%). It is possible that
complex interventions are tested somewhat less than our
results suggest because of responder bias although we
Table 1: The degree and influence of pre-trial testing for 42 complex intervention trials.
Would more or better testing have produced a more effective intervention?
Was the intervention 
tested?1
Yes No Unclear Totals
Yes – extensively 4 11 1 16
Yes – to some degree 5 11 2 18
N o 4408
Totals 13 26 3 42
Was the test phase mentioned in the published article?2
Was the intervention 
tested?1
Yes No Totals
Yes – extensively 10 6 16
Yes – to some degree 7 11 18
No - 8 8
Totals 17 25 42
1 Testing was categorised (by ST) as 'extensive' if the respondent considered the study a pilot, or mentioned substantial experience with similar 
interventions, tests of the complete intervention package running for several months, previously published pilot work, exploratory trials or the 
respondent described testing as extensive. All other testing was categorised as 'to some degree'.
2 Done by checking the text of the respondent's 2004 publication identified by our search.
Table 2: Would more testing have made a difference?
"Yes, absolutely. Legal constraints prevented proper implementation of the supply-side intervention. This constraint should have been detected 
(and resolved) before the [start of the trial]"
"...the number of young children eligible for the program and tracked by the information system degraded over time. Proper piloting of both the 
information system and the public communication campaign should have reduced this attrition."
"Piloting of recruitment and assessment and compliance rates would have been helpful but no funding for time to do this."
"I think there are ways that we could have improved the assistance package, but it was ready to be tested at the time we did the intervention trial."
"A full pilot phase would have alerted us to some of problems encountered such as inadequate team working."
"Almost certainly. The more the better really – in particular in depth interviews with providers and recipients of the pilot intervention or piloting in 
more than one setting could have resulted ultimately in an even more robust intervention."
"With hindsight what might have been useful would have been more data on exactly what happened in the black boxes to see which components 
were responsible for any benefits gained."
"Answer has to be yes but only if one had enough funds and time to do multiple tests."BMC Medical Research Methodology 2006, 6:28 http://www.biomedcentral.com/1471-2288/6/28
Page 4 of 5
(page number not for citation purposes)
have no way of knowing this. However, we believe that
such a bias, if it exists, will reduce but not reverse our main
finding: that most complex interventions are tested but
that this testing is often not reported.
For responders, even extensive development work involv-
ing randomised controlled trials or multi-site pilots run-
ning for many weeks can fail to be mentioned in the trial
report. This can be due to space restrictions imposed by
journals (several respondents cited this problem), or a
belief that early development work is unlikely to be con-
sidered interesting enough for journals to publish. This is
a shame since without this information it may not be pos-
sible to judge whether a trial result could be improved
with a better intervention, whether the intervention and
its delivery are already optimal, or whether further work
with a different intervention is required.
When there is testing, it is no surprise that this generally
leads to changes to the intervention and/or its delivery.
Testing can also lead to substantial changes to trial design.
A minority of trialists neither tested their interventions
nor believed that more testing would have been benefi-
cial. Most trialists do some testing and even modest test-
ing lasting a few weeks can refine an intervention and its
delivery. If funders were more receptive to supporting, or
even insisted upon, comprehensive pre-trial testing it is
reasonable to believe that fewer suboptimal complex
interventions would enter full-scale trials. The importance
of publishing this pre-trial development work should also
be acknowledged and supported by journal editors, per-
haps in the electronic versions of their journals [5].
Conclusion
Complex interventions are generally tested prior to their
evaluation in a full-scale trial, although the amount of
testing varies. Testing is often not described in trial
reports, which makes it hard to judge whether a trial result
could be improved with a better intervention, or whether
further work with a different intervention is required.
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Appendix
The questionnaire used in the email survey is given below.
Study title: [Title]
Question 1: Was your intervention complex?
The Medical Research Council uses the following defini-
tion of a complex intervention [Medical Research Coun-
cil. A framework for development and evaluation of RCTs
for complex interventions to improve health. April
2000.]:
Table 3: Examples of intervention testing and how this testing influenced the final intervention and trial.
Ways in which the intervention was tested Ways in which testing influenced the intervention or its delivery
A component of the intervention, the guideline flowchart, was piloted in 
a single hospital.
The sequence and flow of questions and recommendations was altered. 
Some minor changes to the wording and format of the guidelines were 
made.
Individual components of the study (eg. data collection, intervention, 
retention strategies) were tested, followed by a small feasibility trial of 
the whole intervention package with, finally, a pilot study involving the 
target population.
The data collection instruments and the intervention were modified. 
Recruitment and retention protocols were also modified.
The computer-based decision support system was user-tested prior to 
the trial.
Improvements to navigation and the user interface were made.
A one-year before-after pilot of the full intervention. Confirmed that the intervention was promising. Highlighted 
communication problems between different health professionals, which 
were addressed before the trial. An extra member of staff (a care 
coordinator) was added to the support team that formed part of the 
intervention.
Three educational videos were shown to people to get comments on 
their potential as an educational intervention.
Using videos as an intervention was abandoned and a completely new 
intervention was designed.
Educational outreach and the reminder system were piloted in one 
geographical area.
Feasibility of this form of intervention was confirmed.
A one-year randomised controlled feasibility study of the full 
intervention.
One comparison arm of the trial was dropped. Training manuals were 
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'Complex interventions in health care, whether therapeu-
tic or preventative, comprise a number of separate ele-
ments which seem essential to the proper functioning of
the intervention although the active ingredient of the
intervention that is effective is difficult to specify.'
With this in mind, do you think that your study involved
a complex intervention? [Response]
Question 2: Testing or piloting the intervention
Can you briefly describe how the intervention was tested
or piloted prior to being evaluated in your trial? We are
particularly interested in knowing whether the full inter-
vention was tested, or whether individual components
were tested in isolation. Pilot studies investigating practi-
cal issues related to the trial (eg. recruitment rate, data col-
lection systems, compliance) are also of interest.
[Response]
Question 3: Using the results of the test or pilot
How did the testing or pilot work influence the interven-
tion used in the final trial?
[Response]
Question 4: Would more testing have made a differ-
ence?
Do you think that more (or different) testing would have
resulted in a more effective intervention than the one used
in your trial?
[Response]
Question 5: Any other comments
[Response]
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